Effects and Safety of Oliceridine in Anesthesia Induction:A Randomised Controlled Trial

NCT07372209 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-01-28

No results posted yet for this study

Summary

to investigate whether oliceridine is safe and effective for induction of anesthesia by comparing henodynamic changes before and after endotracheal intubation with sufentanil

Conditions

  • Intubation
  • Gynecological Laparoscopic Surgery
  • General Anesthetic

Interventions

DRUG

Oliceridine

Oliceridine is diluted to a 1mg/kg injection solution

DRUG

Sufentanil

sufentanil is diluted to a 5μg/ml injection solution

Sponsors & Collaborators

  • Tangshan Maternal and Child Health Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2025-12-15
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07372209 on ClinicalTrials.gov